Alignment Healthcare, Inc.

ALHC Healthcare Healthcare Plans

Alignment Healthcare, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.9 billion, up 46.1% from fiscal 2024. In the quarter to June 2026, revenue grew 31.6%, EPS grew 125.0%, free cash flow fell 229.5% and total debt was flat, each against the same quarter a year earlier. Revenue growth for five consecutive years; insiders bought in the last twelve months.

8.30 0.21 +2.60%
Market cap
$1.7B
P/E
39.5×
Fwd P/E
80.3×
Dividend yield
—
F-score
6/9
Altman Z
5.52
Beneish M
−2.73
Dividend safety
n/a
Dec '17 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
P/E ratio
— 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Piotroski F-Score
— — — 3 4 2 5 6
Altman Z-Score
— — — 4.83 3.81 2.95 3.59 5.52
P/S ratio
— 2.75 2.75 2.07 1.47 0.87 0.79 0.99
P/FCF ratio
— 0.00 0.00 0.00 0.00 0.00 0.00 34.54
Altman Z″-Score (non-manufacturers)
— (2.75) (1.50) 0.09 (1.24) (3.47) (2.32) (0.35)
Beneish M-Score
— — (2.93) (2.79) (2.85) (2.76) (3.30) (2.73)
P/Operating CF
— (259.55) (259.55) (80.23) (14.10) (8.43) (246.40) (77.63)
P/B ratio
— 86.03 86.03 7.90 8.79 10.00 21.26 21.81
Price to Tangible BV
— 0.00 0.00 8.92 10.57 13.40 34.86 27.41
EV/Sales
— 2.68 2.68 1.80 1.29 0.78 0.74 0.92
EV/EBITDA
— 207.45 207.45 0.00 0.00 0.00 0.00 79.46
EV/Operating CF
— 339.94 339.94 (26.68) (40.84) (24.06) 57.49 25.95
EV/FCF
— (319.41) (319.41) (21.64) (26.81) (14.96) (301.30) 32.07
Quick Ratio
— 0.94 1.61 3.14 2.18 1.67 1.78 1.54
Current Ratio
— 0.98 1.72 3.31 2.37 1.84 1.88 1.71
Net Debt/EBITDA
— (4.70) (5.10) 1.98 2.27 1.43 1.97 (6.15)
Debt/Assets
0.00% 71.32% 42.59% 23.87% 25.38% 27.34% 41.10% 30.32%
Debt/Equity
— (1.75) 4.71 0.49 0.67 1.02 3.18 1.80
Asset Turnover
— 7.83 3.61 2.41 2.27 2.98 3.94 4.27
Operating CF/Net income
— (0.21) (0.33) 0.40 0.30 0.40 (0.27) (193.27)
Capex/Depreciation
— (0.55) (0.88) (1.00) (1.23) (2.00) (1.61) (0.86)
Interest Coverage
— (1.98) (0.31) (10.21) (7.03) (6.02) (4.31) 0.93
ROE
— 186.00% 95.33% (116.01%) (54.84%) (74.50%) (98.86%) (0.52%)
ROA
— (46.25%) (8.62%) (40.29%) (23.65%) (24.15%) (18.64%) (0.08%)
ROIC
— 0.00% 0.00% 0.00% 0.00% (7,493.96%) 0.00% 0.00%
Return on Tangible Assets
— (182.30%) (16.57%) (46.95%) (42.51%) (54.33%) (33.97%) (0.16%)
Average Days of Receivables
— 17.18 15.27 18.29 23.64 23.97 20.78 23.41
Research and Development Expense of Revenue
— 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Selling, General and Administrative Expense of Revenue
— 14.55% 16.30% 24.92% 20.61% 16.86% 13.74% 11.23%
Intangible Assets out of Total Assets
0.00 0.18 0.10 0.06 0.06 0.07 0.05 0.03
Share Based Compensation of Revenue
— 0.15% 0.22% 9.47% 5.70% 3.66% 2.63% 1.57%
Graham Net Nets
— (0.02) (0.02) 0.09 0.07 0.03 (0.01) 0.02
Graham Number
— 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Yield
— (0.87%) (0.87%) (8.18%) (7.06%) (9.31%) (6.04%) 0.00%
Free Cash Flow Yield
— (0.31%) (0.31%) (4.02%) (3.29%) (6.02%) (0.31%) 2.90%
Revenue per Share
— 5.57 6.31 6.79 7.91 9.79 14.17 19.94
Operating CF per Share
— 0.07 0.05 (0.46) (0.25) (0.32) 0.18 0.71
Capex per Share
— (0.08) (0.10) (0.11) (0.13) (0.19) (0.22) (0.13)
Free Cash Flow per Share
— (0.01) (0.05) (0.56) (0.38) (0.51) (0.03) 0.57
Cash per Share
— 0.64 1.36 2.71 2.26 1.71 2.47 3.05
Shareholders Equity per Share
— (0.58) 0.20 1.78 1.32 0.85 0.53 0.91
Interest Debt per Share
— 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
— (0.58) 0.20 1.78 1.32 0.85 0.53 0.91
Free Cash Flow
— (1.04) (8.05) (97.14) (69.20) (95.18) (6.63) 113.22
Working Capital
— (2.90) 111.22 385.61 314.59 220.52 309.79 394.71
Capital Expenditures
— (10.24) (15.61) (18.36) (23.77) (35.99) (41.40) (26.71)
Net Current Asset Value
— (144.80) (43.21) 228.02 149.99 49.73 (19.47) 65.07
EV/EBIT
— 0.00 0.00 0.00 0.00 0.00 0.00 246.15
Capex to Sales
— 0.01 0.02 0.02 0.02 0.02 0.02 0.01
Price to Operating Income
— 0.00 0.00 0.00 0.00 0.00 0.00 265.09
Other line items
Depreciation/Fixed assets
— 0.68 0.65 0.60 0.52 0.35 0.38 0.48
Cash ROIC
— (0.71%) (2.11%) (10.52%) (8.55%) (14.90%) (0.74%) 10.23%
Accounts Receivable Turnover
— 19.98 25.32 23.67 18.95 17.15 19.76 19.40
Accounts Payable Turnover
— 5.38 6.45 7.65 7.23 7.52 8.90 8.44
Inventory Turnover
— 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Average Days of Payables
— 64.97 59.05 50.35 59.11 51.49 47.30 53.57
Days of Inventory on Hand
— 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Average Receivables
— 37.89 37.89 49.33 75.70 106.32 136.83 203.56
Average Payables
— 123.01 123.01 135.80 172.87 215.67 270.41 409.88
Average Assets
— 96.72 265.97 484.70 632.38 612.87 686.97 923.92
Average Common Equity
— (24.05) (24.05) 168.33 272.68 198.69 129.51 140.12

Fold the line items

Columns are period end dates